91ºÚÁÏ

91ºÚÁÏ offers the knowledge, software, systems and global footprint to make global adaptive trials a reality.

Ensuring the highest levels of safety and accuracy in your trials.

91ºÚÁÏ provides a range of integrated services that cover the planning, management, execution and analysis of Phase II ¨C IIIb trials.

91ºÚÁÏ Consulting Services provides strategic analysis to support improved decision-making in drug and device development.

91ºÚÁÏ provides expertise to accelerate market access and drive product adoption.

91ºÚÁÏ experts can help to implement patient-centric, alternative trial models - from the integration of digital health technologies to in-home clinical visits and agile monitoring solutions. 

91ºÚÁÏ specialises in the strategy and delivery of early phase clinical development.

91ºÚÁÏ provides laboratory services through our global Central Laboratories, Bioanalytical Laboratory and Specialty Laboratories.

91ºÚÁÏ is the industry's largest life sciences language services provider.

91ºÚÁÏ provides medical imaging based product development services that expedite drug development.

91ºÚÁÏ optimises real world data use to drive effective outcomes and achieve regulatory authorisation

Transforming recruitment through patient-centric trials and real-world, real-time data.

91ºÚÁÏ is redefining FSP to provide sponsors with flexibility to meet the demands of modern drug development.